Evoke Pharma (EVOK) Short Interest Ratio & Short Volume $4.33 -0.17 (-3.78%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Evoke Pharma Short Interest DataEvoke Pharma (EVOK) has a short interest of 101,000 shares, representing 7.43% of the float (the number of shares available for trading by the public). This marks a 288.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.17 million shares to cover all short positions.Current Short Interest101,000 sharesPrevious Short Interest26,000 sharesChange Vs. Previous Month+288.46%Dollar Volume Sold Short$590,850.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,490,000 sharesFloat Size1,360,000 sharesShort Percent of Float7.43%Today's Trading Volume37,497 sharesAverage Trading Volume1,173,705 sharesToday's Volume Vs. Average3% Short Selling Evoke Pharma? Sign up to receive the latest short interest report for Evoke Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVOK Short Interest Over TimeEVOK Days to Cover Over TimeEVOK Percentage of Float Shorted Over Time Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Evoke Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024101,000 shares $590,850.00 +288.5%7.4%0.2 $5.85 10/15/202426,000 shares $132,860.00 -72.3%3.5%0.4 $5.11 9/30/202493,900 shares $446,964.00 +43.1%12.5%1.3 $4.76 9/15/202465,600 shares $282,736.00 -15.3%8.8%1 $4.31 8/31/202477,400 shares $332,046.00 +2,176.5%10.4%1.3 $4.29 8/15/20243,400 shares $18,972.00 +61.9%0.5%0.1 $5.58 Get the Latest News and Ratings for EVOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/20242,100 shares $10,248.84 -78.6%0.3%0.6 $4.88 7/15/20249,800 shares $5,782.01 -13.3%0.1%0.4 $0.59 6/30/202411,300 shares $5,977.70 -54.4%0.2%0.4 $0.53 6/15/202424,800 shares $11,703.12 +40.1%0.3%0.9 $0.47 5/31/202417,700 shares $8,407.50 -56.5%0.2%0.5 $0.48 5/15/202440,700 shares $19,067.95 +6.0%0.6%1.2 $0.47 4/30/202438,400 shares $17,587.20 +4.9%0.6%1 $0.46 4/15/202436,600 shares $17,392.32 -31.5%0.5%0.9 $0.48 3/31/202453,400 shares $32,574.00 -25.9%0.8%0.9 $0.61 3/15/202472,100 shares $44,702.00 +21.8%1.1%1.2 $0.62 2/29/202459,200 shares $39,184.48 -73.1%0.7%1.1 $0.66 2/15/2024219,800 shares $153,860.00 -46.1%2.7%4.3 $0.70 1/31/2024407,900 shares $277,372.00 +419.0%12.5%9.1 $0.68 1/15/202478,600 shares $58,950.00 +83.2%2.4%2.2 $0.75 12/31/202342,900 shares $45,057.87 +371.4%1.3%3.4 $1.05 12/15/20239,100 shares $10,920.00 -43.8%0.3%0.6 $1.20 11/30/202316,200 shares $21,019.50 -28.0%0.5%1.2 $1.30 11/15/202322,500 shares $28,575.00 +54.1%0.7%1.8 $1.27 10/31/202314,600 shares $16,936.00 -51.8%0.5%1.1 $1.16 10/15/202330,300 shares $38,484.03 +41.6%0.9%2 $1.27 9/30/202321,400 shares $29,532.00 +20.9%0.7%1.4 $1.38 9/15/202317,700 shares $20,532.00 +391.7%0.5%1.4 $1.16 8/31/20233,600 shares $4,467.60 -76.9%0.1%0.1 $1.24 8/15/202315,600 shares $20,280.00 +136.4%0.5%0.6 $1.30 7/31/20236,600 shares $10,692.00 +1.5%0.2%0.2 $1.62 7/15/20236,500 shares $11,051.30 -57.0%0.2%0.2 $1.70 6/30/202315,100 shares $24,764.00 -65.8%0.5%0.5 $1.64 6/15/202344,100 shares $73,232.46 +390.0%1.4%1.4 $1.66 5/31/20239,000 shares $14,670.00 -65.5%0.3%0.4 $1.63 5/15/202326,100 shares $50,265.99 +107.1%0.8%1.5 $1.93 4/30/202312,600 shares $23,640.12 +12.5%0.4%0.7 $1.88 4/15/202311,200 shares $21,728.00 -7.4%0.3%0.4 $1.94 3/31/202312,100 shares $22,990.00 -67.5%0.4%0.4 $1.90 3/15/202337,200 shares $122,760.00 +42.5%1.1%1 $3.30Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 2/28/202326,100 shares $75,951.00 +54.4%0.8%0.6 $2.91 2/15/202316,900 shares $47,827.00 -71.1%0.5%0.4 $2.83 1/31/202358,500 shares $236,340.00 +61.2%1.8%1.5 $4.04 1/15/202336,300 shares $111,804.00 -33.9%1.1%1.2 $3.08 12/30/202254,900 shares $147,132.00 +42.2%1.7%2.2 $2.68 12/15/202238,600 shares $72,954.00 +27.4%1.2%1.8 $1.89 11/30/202230,300 shares $45,450.00 +14.8%0.9%1.6 $1.50 11/15/202226,400 shares $44,352.00 +7.8%0.8%1.9 $1.68 10/31/202224,500 shares $42,385.00 +12.9%0.8%1.3 $1.73 10/15/202221,700 shares $42,482.09 -18.4%0.7%0.7 $1.96 9/30/202226,600 shares $49,742.00 -25.7%0.8%0.8 $1.87 9/15/202235,800 shares $80,550.00 +26.1%1.1%0.8 $2.25 8/31/202228,400 shares $76,680.00 -52.5%N/A0 $2.70 8/15/202259,800 shares $163,852.00 +76.9%N/A0.1 $2.74 7/31/202233,800 shares $103,090.00 -44.7%N/A0 $3.05 7/15/202261,100 shares $189,410.00 -61.9%N/A0.1 $3.10 6/30/2022160,400 shares $519,696.00 +83.1%N/A0.1 $3.24 6/15/202287,600 shares $262,800.00 +47.5%N/A0.1 $3.00 5/31/202259,400 shares $159,786.00 +70.7%N/A0.1 $2.69 5/15/202234,800 shares $113,879.52 -98.0%N/A0.1 $3.27 4/30/20221,770,000 shares $831,900.00 +1,906.8%5.7%0.4 $0.47 4/15/202288,200 shares $33,780.60 -37.5%0.3%0.8 $0.38 3/31/2022141,200 shares $69,894.00 -19.0%N/A0 $0.50 3/15/2022174,400 shares $80,224.00 +4.8%0.6%1.2 $0.46 2/28/2022166,400 shares $106,163.20 -23.3%0.5%0.6 $0.64 2/15/2022217,000 shares $145,932.50 -6.9%0.7%0.7 $0.67 1/31/2022233,000 shares $127,031.60 +70.6%0.7%0.7 $0.55 1/15/2022136,600 shares $69,474.76 -0.9%N/A0.4 $0.51 12/31/2021137,800 shares $75,790.00 -25.1%0.4%0.4 $0.55 12/15/2021184,000 shares $115,000.00 -39.3%0.6%0.6 $0.63 11/30/2021303,300 shares $230,477.67 -28.6%1.0%1.3 $0.76 11/15/2021424,500 shares $424,500.00 -16.8%1.3%2.4 $1.00 10/29/2021509,900 shares $627,177.00 -12.0%1.6%1 $1.23 10/15/2021579,100 shares $799,158.00 +4.3%1.8%1.2 $1.38 9/30/2021555,300 shares $721,890.00 -2.0%1.8%1.1 $1.30 9/15/2021566,500 shares $628,815.00 -13.3%1.8%1.1 $1.11 8/31/2021653,200 shares $764,244.00 +42.0%2.1%1.3 $1.17 8/13/2021460,000 shares $616,400.00 -13.9%1.5%0.8 $1.34 7/30/2021534,500 shares $598,640.00 -28.7%1.7%2.1 $1.12 7/15/2021749,900 shares $922,377.00 +33.8%2.4%2.7 $1.23 6/30/2021560,300 shares $767,611.00 -31.5%1.8%1.8 $1.37 6/15/2021818,400 shares $1.10 million -17.2%2.6%2.3 $1.35 5/28/2021988,100 shares $1.22 million -14.8%3.4%1.9 $1.23 5/14/20211,160,000 shares $1.32 million -7.2%N/A2.3 $1.14 4/30/20211,250,000 shares $2.13 million +14.7%N/A1.8 $1.70 4/15/20211,090,000 shares $1.85 million -2.7%N/A0 $1.70 3/31/20211,120,000 shares $1.98 million +46.7%N/A1.4 $1.77 3/15/2021763,500 shares $1.87 million +4.4%N/A1 $2.45 2/26/2021731,700 shares $2.28 million +48.2%N/A1.2 $3.11 2/12/2021493,800 shares $1.70 million +26.8%N/A0.8 $3.45Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 1/29/2021389,400 shares $981,288.00 -55.2%N/A0.7 $2.52 1/15/2021869,300 shares $2.53 million +56.4%N/A2.5 $2.91 12/31/2020555,800 shares $1.50 million +18.4%N/A2.3 $2.69 12/15/2020469,300 shares $1.38 million +37.5%N/A2 $2.95 11/30/2020341,300 shares $1.04 million -4.3%N/A1.5 $3.04 11/15/2020356,800 shares $1.32 million +0.2%1.5%1.4 $3.71 10/30/2020356,100 shares $1.42 million -38.6%1.6%1.3 $3.99 10/15/2020580,200 shares $2.79 million +8.5%2.5%1.6 $4.81 9/30/2020534,800 shares $2.51 million -11.4%2.3%1.3 $4.69 9/15/2020603,300 shares $2.95 million -2.2%2.6%1.1 $4.89 8/31/2020617,100 shares $2.76 million -10.4%2.7%0.4 $4.47 8/14/2020688,500 shares $3.92 million +14.4%3.0%0.4 $5.70 7/31/2020601,700 shares $2.22 million -31.5%2.6%0.4 $3.69 7/15/2020878,000 shares $3.19 million -28.0%4.0%0.6 $3.63 6/30/20201,220,000 shares $4.25 million +293.9%5.6%0.8 $3.48 6/15/2020309,700 shares $740,183.00 +13.8%1.4%0.2 $2.39 5/29/2020272,200 shares $672,334.00 +120.4%1.2%0.7 $2.47 5/15/2020123,500 shares $174,135.00 +27.5%0.6%0.4 $1.41 4/30/202096,900 shares $128,877.00 -4.0%0.5%0.6 $1.33 4/15/2020100,900 shares $125,116.00 -25.1%0.5%0.6 $1.24 3/31/2020134,700 shares $157,599.00 -42.9%0.6%0.8 $1.17 3/13/2020235,900 shares $259,490.00 -7.9%1.1%1.2 $1.10 2/28/2020256,100 shares $225,368.00 -25.7%1.2%1.2 $0.88 2/14/2020344,500 shares $413,400.00 -12.2%1.6%1.4 $1.20 1/31/2020392,400 shares $537,588.00 -30.0%1.9%1.3 $1.37 1/15/2020560,200 shares $795,484.00 +4.9%2.7%1.9 $1.42 12/31/2019534,100 shares $795,809.00 -25.3%2.5%2.1 $1.49 EVOK Short Interest - Frequently Asked Questions What is Evoke Pharma's current short interest? Short interest is the volume of Evoke Pharma shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 101,000 shares of EVOK short. 7.43% of Evoke Pharma's shares are currently sold short. Learn More on Evoke Pharma's current short interest. What is a good short interest percentage for Evoke Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.43% of Evoke Pharma's floating shares are currently sold short. Is Evoke Pharma's short interest increasing or decreasing? Evoke Pharma saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 101,000 shares, an increase of 288.5% from the previous total of 26,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Evoke Pharma's float size? Evoke Pharma currently has issued a total of 1,486,000 shares. Some of Evoke Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evoke Pharma currently has a public float of 1,360,000 shares. How does Evoke Pharma's short interest compare to its competitors? 7.43% of Evoke Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evoke Pharma: Eyenovia, Inc. (2.48%), Lipocine Inc. (1.45%), Marker Therapeutics, Inc. (1.09%), DURECT Co. (3.35%), Natural Alternatives International, Inc. (0.17%), Pluri Inc. (0.24%), BioLineRx Ltd. (1.33%), Athira Pharma, Inc. (4.38%), Equillium, Inc. (0.68%), GeoVax Labs, Inc. (3.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Evoke Pharma stock? Short selling EVOK is an investing strategy that aims to generate trading profit from Evoke Pharma as its price is falling. EVOK shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evoke Pharma? A short squeeze for Evoke Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVOK, which in turn drives the price of the stock up even further. How often is Evoke Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVOK, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies EYEN Short Interest Data LPCN Short Interest Data MRKR Short Interest Data DRRX Short Interest Data NAII Short Interest Data PLUR Short Interest Data BLRX Short Interest Data ATHA Short Interest Data EQ Short Interest Data GOVX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVOK) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
